IGF-1 LR3 5mg — Vial Spec, Reconstitution Math & COA

IGF-1 LR3 5mg Specification and Product Availability

The 5mg vial specification of IGF-1 LR3 delivers a bulk lyophilized quantity designed specifically for high-frequency or high-volume laboratory experimentation. Containing 5,000 mcg of active sequence, this format reduces lot-to-lot variance across multi-plate cellular assays, signal transduction studies, and cell proliferation experiments. Laboratories evaluating muscle cell differentiation, Akt/mTOR kinase pathways, or glucose transport mechanisms often require larger single-lot quantities to eliminate experimental noise introduced by reconstituted batch switching.

PX1 Research manufactures and packages high-purity recombinant peptides adhering strictly to cGMP-compliant standards. While specialized high-throughput projects utilize 5mg configurations, standard single-protocol evaluations frequently utilize our standard 1mg IGF-1 LR3 format. Qualified institutional researchers seeking specialized 5mg fills, custom vial configurations, or bulk batch allocations can review full inventory options across our all peptides catalog or submit custom requests through our dedicated enterprise procurement channel.

Molecular Structure, Receptor Affinity, and Half-Life Dynamics

Insulin-like Growth Factor-1 Long R3 (IGF-1 LR3) is a synthetic 83-amino-acid analog of native human IGF-1. The primary sequence modification consists of an amino acid substitution—glutamic acid (Glu) replaced by arginine (Arg) at position 3—alongside a 13-amino-acid N-terminal extension peptide. This molecular re-engineering significantly alters the pharmacokinetic profile of the peptide in cell culture and animal model systems.

In native biological systems, IGF-binding proteins (IGFBPs 1 through 6) bind wild-type IGF-1 with high affinity, regulating its bioactivity and rapidly sequestering the free peptide. The Arg3 substitution combined with the N-terminal extension in IGF-1 LR3 reduces its affinity for IGFBPs by over 100-fold while maintaining full agonistic binding affinity for the type 1 IGF receptor (IGF-1R). Preclinical studies indicate that by evading binding protein sequestration, IGF-1 LR3 exhibits a substantially prolonged active half-life in vitro, promoting sustained activation of intracellular tyrosine kinase domains and downstream signaling cascades.

Reconstitution Mathematics for 5mg (5,000 mcg) Vials

Accurate volumetric reconstitution of a 5mg vial is critical for maintaining exact working concentrations in laboratory assays. Because a 5mg vial contains 5,000 micrograms of total peptide mass, small variations in diluent volume lead to significant shifts in microgram-per-microliter metrics. Researchers should utilize precise variable-volume micro-pipettes calibrated to ISO 8655 standards when preparing stock solutions.

The mathematical formula to determine concentration ($C$) is total peptide mass ($M$) divided by total diluent volume ($V$): $C = M / V$. Below are the precise volumetric calculations for standard reconstitution volumes added to a 5mg mass vial:

1.0 mL Diluent Addition: 5,000 mcg / 1.0 mL = 5,000 mcg/mL (5.0 mcg/µL or 5.0 ng/nL). A standard 10 µL assay aliquot yields exactly 50 mcg of active peptide.

2.0 mL Diluent Addition: 5,000 mcg / 2.0 mL = 2,500 mcg/mL (2.5 mcg/µL). A 10 µL assay aliquot yields exactly 25 mcg of active peptide.

3.0 mL Diluent Addition: 5,000 mcg / 3.0 mL = 1,666.67 mcg/mL (1.67 mcg/µL). A 10 µL assay aliquot yields 16.67 mcg of active peptide.

5.0 mL Diluent Addition: 5,000 mcg / 5.0 mL = 1,000 mcg/mL (1.0 mcg/µL). A 10 µL assay aliquot yields exactly 10 mcg of active peptide.

To quickly verify custom reconstitution volumes and calculate precise volumetric draw requirements for microplate dilutions, researchers can access our interactive reconstitution calculator.

Diluent Selection Chemistry and Solubilization Protocol

Reconstituting IGF-1 LR3 requires strict adherence to solvent chemistry principles. Recombinant growth factors featuring complex disulfide bond arrangements and hydrophobic regions are prone to rapid surface adsorption, aggregation, and precipitation when dissolved in neutral pH aqueous solutions such as standard 0.9% Sodium Chloride or plain Sterile Water for Injection.

To ensure complete solubilization and long-term chemical stability, initial reconstitution must be conducted using an acidic aqueous diluent—specifically 0.1% acetic acid (pH ~2.7–3.0). The protonated environment maintains the peptide's electrostatic charge, preventing hydrophobic self-aggregation and adhesion to borosilicate glass vial walls. For working assay solutions that require neutral pH, the primary acidic stock solution should be diluted directly into culture media containing carrier proteins (such as 0.1% BSA or HSA) immediately prior to application.

Aliquot Planning and Cryogenic Storage Protocols

Because 5mg represents a substantial peptide volume, repeated freeze-thaw cycles of a single reconstituted stock vial will lead to peptide bond cleavage, oxidation, and rapid loss of bioactivity. Establishing a clear aliquot protocol immediately following initial solubilization is mandatory for preserving structural integrity.

Lyophilized Powder Storage: Store intact, sealed vials at -20°C to -80°C in a low-humidity freezer environment. Unopened lyophilized vials stored at -80°C remain stable for up to 24 months from the date of manufacture.

Reconstituted Stock Storage: Upon solubilization in 0.1% acetic acid, partition the solution into single-use microcentrifuge tubes (e.g., polypropylene, low-binding tubes) at concentrations suited for daily experimental runs (e.g., 50 µL to 100 µL aliquots). Standard polypropylene tubes minimize peptide binding.

Flash-freeze the individual aliquots in liquid nitrogen or a dry ice/ethanol bath, then store at -80°C. Individual aliquots should be thawed once on ice immediately prior to assay administration; unused portions of thawed aliquots must be discarded to prevent degraded data artifacts.

Analytical Certificate of Analysis (COA) and Lot Verification

Every batch of PX1 Research peptides undergoes comprehensive third-party testing in ISO 17025 accredited analytical laboratories prior to distribution. We provide transparent verification for every production fill size, ensuring that the material delivered matches theoretical physical parameters precisely.

The lot-matched Certificate of Analysis (COA) confirms three primary parameters: high-performance liquid chromatography (HPLC) purity (>98.0%), matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) sequence validation confirming the exact molecular weight of 9,111 Da, and Limulus Amebocyte Lysate (LAL) endotoxin testing confirming levels below strictly controlled research thresholds (<0.01 EU/µg). Researchers can access batch reports directly via our central COA verification directory.

Comparative Analysis: IGF-1 LR3 vs. IGF-1 DES and MGF

In cell culture and tissue model research, investigators often evaluate multiple growth factor constructs to map distinct kinetic responses. Within the insulin-like growth factor superfamily, structural modifications alter binding duration, local potency, and tissue specificity. A comparative summary illustrates how IGF-1 LR3 compares against related research peptides in the same structural class:

While Long R3 IGF-1 exhibits sustained signaling due to low binding-protein affinity, truncated analogs such as IGF-1 DES lack the N-terminal tripeptide (Gly-Pro-Glu), producing extreme local receptor potency with a shortened half-life ideal for acute, localized exposure models. Conversely, splice variants like Mechano-Growth Factor (MGF) activate distinct signaling cascades responsible for early-stage myoblast stem cell activation rather than mature cell hypertrophy. Comparing these profiles enables researchers to select the precise tool required for specific cell culture parameters.

Preclinical Research Applications in In Vitro Systems

Preclinical literature demonstrates that IGF-1 LR3 serves as a robust tool for investigating insulin-like signaling cascades in diverse cellular lines. In vitro assays using C2C12 myoblasts demonstrate that stimulation with IGF-1 LR3 accelerates myotube formation through the phosphorylation of Akt and downstream activation of mammalian target of rapamycin (mTOR) pathways.

Furthermore, animal models evaluating metabolic transport mechanisms demonstrate that IGF-1 LR3 stimulates glucose uptake and amino acid transport independent of ambient insulin concentrations. These characteristics make the compound a benchmark reference standard in non-clinical studies investigating muscle wasting conditions, metabolic dysfunction, and cellular longevity.

Selecting the Optimal Configuration: 1mg vs. 5mg vs. Bulk

Selecting the appropriate vial mass depends on experimental scale, laboratory throughput, and handling capabilities. Utilizing an oversized vial size for small-scale pilot studies can lead to unnecessary peptide degradation over extended storage periods.

Choose 1mg Vials: Ideal for pilot assays, low-volume cell culture protocols, or sporadic testing where stock solutions will be consumed within 30 days of reconstitution.

Choose 5mg Vials: Ideal for medium-to-large academic laboratories running continuous multi-well assays over several weeks. Reconstitution of a 5mg vial allows uniform batching across multi-plate experiments.

Choose Bulk Orders: Institutional core facilities executing long-term animal model studies or large-scale screening screens should request custom bulk fill allocations directly through our wholesale laboratory portal to obtain single-lot consistency across multi-gram requirements.

Laboratory Handling, Safety, and Regulatory Compliance

All research compounds supplied by PX1 Research are intended strictly for in vitro laboratory research and calibrated preclinical evaluation. These substances are not for human or veterinary use, administration, or clinical application.

Laboratory personnel handling lyophilized or reconstituted IGF-1 LR3 must utilize appropriate personal protective equipment (PPE), including nitrile gloves, safety goggles, and laboratory coats. Handling should occur within a certified Class II Biosafety Cabinet or chemical fume hood to prevent accidental inhalation or aerosol generation. All waste products, including used vials and micropipette tips, must be disposed of in accordance with institutional biohazard safety guidelines.